07 Jan 2001

Doxycyclin Atid (Doxycyclin Atid 100 mg Filmtabletten) - Deutschland

Updated: 07 Jan 2001

Doxycyclin Atid 100 mg

Infektionen, d. durch Doxycyclin empfindliche Erreger ausgelöst werden wie Infektionskrankheiten d. Haut (schwere Formen von Akne vulgaris u. Akne conglobata, Rosacea), Infektionen d. Atemwege u. d. HNO-Bereiches: akute Schübe chronischer Bronchitiden, Sinusitis, Otitis media, Pneumonien durch Mykoplasmen, Rickettsien u. Chlamydien; Infektionen d. Urogenitaltraktes: Urethritis durch Chlamydien u. Ureaplasma urealyticum, akute Prostatitis, unkomplizierte Gonorrhoe (insbes. b. gleichz. Chlamydieninfektion); Infektionen d. weiblichen Geschlechtsorgane, Syphilis bei Penicillinallergie, Harnwegsinfektionen (nur b. nachgewiesener Empfindlichkeit); Infektionen u. andere Erkrankungen d. Magen-Darm-Traktes: Cholera, Yersinien- u. Campylobacter-Infektionen, Shigellen b. Nachweis d. Empfindlichkeit, Malabsorptions-Syndrome wie tropische Sprue u. Morbus Whipple. Ambulante Therapie von Gallenwegsinfektionen, Chlamydien- Konjunktivitis u. Trachom, Borreliosen wie Erythema chronicum migrans u. Lyme-Disease, seltene Infektionen wie Brucellose, Ornithose, Bartonellose, Listeriose, Rickettsiose, Melioidose, Pest, Granuloma inguinale. Infektionen mit Verdacht auf Beteiligung von Staphylokokken, Streptokokken u. Pneumokokken sollten wegen d. unterschiedlichen Resistenzsituation mit Doxycyclin nicht behandelt werden.

Doxycyclin Atid Description, Presentation and Dosage

Doxycyclin Atid Description

Doxycyclin Atid Drug Class Description

Doxycyclin

Doxycyclin Atid Drug Description

1 Filmtbl. enth.: Doxycyclin-HCl ½C2H5OH ½H2O 115,4 mg (entspr. 100 mg Doxycyclin).

Doxycyclin Atid Generic Name

Doxycyclin Atid 100 mg Filmtabletten

Doxycyclin Atid Presentation

Doxycyclin Atid Presentation

Doxycyclin Atid 100 mg

Doxycyclin Atid Manufacturer

Atid Pharma

Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Doxycyclin Atid Dosage

Doxycyclin Atid Adult Dosage

Lactose, mikrokristalline Cellulose, Copovidon, Maisstärke, Magnesiumstearat, hochdisperses Siliciumdioxid, Hypromellose, Macrogol, Carnaubawachs, Farbstoffe E 171, E 124, E 104.

Doxycyclin Atid Precautions, Reactions and Contraindications

Doxycyclin Atid Special Precautions

Doxycyclin Atid Special Precautions

T 15

Doxycyclin Atid Adverse Reactions

Doxycyclin Atid Adverse Reactions

T 15

Related Drugs - Infectious Diseases

Back to top